Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
347.00
+12.50 (3.74%)
At close: Sep 1, 2025

SHA:688506 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
439.665,821560.42701.83794.951,011
Upgrade
Other Revenue
1.521.671.461.451.781.66
Upgrade
441.195,823561.87703.28796.731,013
Upgrade
Revenue Growth (YoY)
-92.40%936.31%-20.11%-11.73%-21.33%-16.07%
Upgrade
Cost of Revenue
262.81283.74242.26237.7203.39202.02
Upgrade
Gross Profit
178.385,539319.61465.58593.34810.69
Upgrade
Selling, General & Admin
460405.04367.89403.01467.46636.86
Upgrade
Research & Development
1,9371,443746.23375.02278.6195.7
Upgrade
Other Operating Expenses
31.194.24-2.279.799.173
Upgrade
Operating Expenses
2,4281,8531,105795.41752.86833.55
Upgrade
Operating Income
-2,2503,686-785.6-329.83-159.52-22.85
Upgrade
Interest Expense
-60.34-42.52-24.68-22.48-8.69-7.57
Upgrade
Interest & Investment Income
256.26225.325.710.773.614.75
Upgrade
Currency Exchange Gain (Loss)
23.0863.88-1.11-0.05-0.14-
Upgrade
Other Non Operating Income (Expenses)
-1.06-3.38-0.84-0.56-0.350.02
Upgrade
EBT Excluding Unusual Items
-2,0323,930-806.51-352.16-165.09-25.66
Upgrade
Gain (Loss) on Sale of Investments
2.7411.44---0.34
Upgrade
Gain (Loss) on Sale of Assets
-0.33-0.22-0.14-0.48-0.45-
Upgrade
Asset Writedown
------0.17
Upgrade
Other Unusual Items
52.0137.337.6463.5761.171.11
Upgrade
Pretax Income
-1,9773,978-769.01-289.07-104.4445.62
Upgrade
Income Tax Expense
99.3270.6511.49-6.69-4.457.7
Upgrade
Earnings From Continuing Operations
-2,0773,708-780.5-282.38-99.9937.92
Upgrade
Minority Interest in Earnings
------0.02
Upgrade
Net Income
-2,0773,708-780.5-282.38-99.9937.9
Upgrade
Net Income to Common
-2,0773,708-780.5-282.38-99.9937.9
Upgrade
Net Income Growth
-----390.26%
Upgrade
Shares Outstanding (Basic)
401401400362357345
Upgrade
Shares Outstanding (Diluted)
401401400362357345
Upgrade
Shares Change (YoY)
0.05%0.14%10.56%1.38%3.64%-10.86%
Upgrade
EPS (Basic)
-5.189.25-1.95-0.78-0.280.11
Upgrade
EPS (Diluted)
-5.189.25-1.95-0.78-0.280.11
Upgrade
EPS Growth
-----450.00%
Upgrade
Free Cash Flow
-2,2713,975-697.29-293.21-179.6363.09
Upgrade
Free Cash Flow Per Share
-5.679.92-1.74-0.81-0.500.18
Upgrade
Gross Margin
40.43%95.13%56.88%66.20%74.47%80.05%
Upgrade
Operating Margin
-509.95%63.31%-139.82%-46.90%-20.02%-2.26%
Upgrade
Profit Margin
-470.73%63.67%-138.91%-40.15%-12.55%3.74%
Upgrade
Free Cash Flow Margin
-514.76%68.26%-124.10%-41.69%-22.55%6.23%
Upgrade
EBITDA
-2,1793,754-727.25-272.27-109.3726.45
Upgrade
EBITDA Margin
-64.48%-129.43%-38.71%-13.73%2.61%
Upgrade
D&A For EBITDA
70.6367.958.3457.5650.1649.31
Upgrade
EBIT
-2,2503,686-785.6-329.83-159.52-22.85
Upgrade
EBIT Margin
-63.31%-139.82%-46.90%-20.02%-2.26%
Upgrade
Effective Tax Rate
-6.80%---16.87%
Upgrade
Revenue as Reported
441.195,823561.87703.28796.731,013
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.